AVTXVSMRNA• 28 Days (Normalized)
AVTX vs MRNA (Avalo Therapeutics Inc. vs Moderna Inc.)
Showing Closing Date Range from Aug, 17 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVTX Performance $16.18
-18.9%
Avalo Therapeutics Inc.
Normalized Baseline0.00%
MRNA Performance $146.69
+127.57%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-146.47%
MRNA outperforming by 146.47%
AVTXMRNA
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVTX MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | AVTX Price | AVTX Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $16.18 | -18.90% | $146.69 | +127.57% | -146.47% |
| Sep 11, 2026 | $16.12 | -19.20% | $143.97 | +123.35% | -142.55% |
| Sep 10, 2026 | $17.18 | -13.88% | $136.62 | +111.95% | -125.83% |
| Sep 09, 2026 | $18.21 | -8.72% | $135.61 | +110.38% | -119.10% |
| Sep 08, 2026 | $19.71 | -1.20% | $140.33 | +117.70% | -118.90% |
| Sep 04, 2026 | $19.23 | -3.61% | $145.55 | +125.80% | -129.41% |
| Sep 03, 2026 | $19.00 | -4.76% | $148.87 | +130.95% | -135.71% |
| Sep 02, 2026 | $19.34 | -3.06% | $150.81 | +133.96% | -137.02% |
| Sep 01, 2026 | $18.95 | -5.01% | $154.27 | +139.33% | -144.34% |
| Aug 31, 2026 | $19.34 | -3.06% | $140.34 | +117.72% | -120.78% |
| Aug 28, 2026 | $19.59 | -1.80% | $137.99 | +114.07% | -115.87% |
| Aug 27, 2026 | $20.05 | +0.50% | $142.77 | +121.49% | -120.99% |
| Aug 26, 2026 | $20.55 | +3.01% | $149.66 | +132.17% | -129.16% |
| Aug 25, 2026 | $19.74 | -1.05% | $158.83 | +146.40% | -147.45% |
| Aug 24, 2026 | $19.27 | -3.41% | $138.89 | +115.47% | -118.88% |
Page 1 of 2